PUBLISHER: The Business Research Company | PRODUCT CODE: 1945291
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945291
Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices are specialized instruments designed for cutting, dissecting, grasping, and suturing tissues in surgical procedures involving the liver (hepato-), pancreas (pancreatic-), and bile ducts (biliary). These devices play a crucial role in performing intricate procedures on these delicate organs.
The main products in the field of hepato-pancreatic-biliary (HPB) surgeries surgical devices include electrosurgery instruments, endoscopes, hand instruments, access instruments, stents, energy/vessel sealing devices, visualization and robotic surgical systems, surgical suture and stapler devices, and fluid management systems. Electrosurgery instruments utilize high-frequency, alternating electric current to generate heat in tissues, enabling various surgical procedures such as cutting, coagulating, desiccating, or fulgurating tissue. These devices find indications in the treatment of conditions such as liver cancer, pancreatic cancer, gallstones, bile duct cancer, cirrhosis, pancreatitis, and cholecystitis. They are commonly used in hospitals, specialty clinics, trauma centers, and ambulatory surgical centers.
Tariffs are impacting the HPB surgeries surgical devices market by increasing costs of imported electrosurgical systems, robotic components, visualization equipment, stents, and precision hand instruments used in complex procedures. Hospitals and specialty surgical centers in North America and Europe are most affected due to dependence on imported high-end surgical technologies, while Asia-Pacific faces increased manufacturing and export costs. These tariffs are raising capital investment requirements and slowing equipment upgrades. However, they are also driving localized manufacturing, regional assembly, and innovation in cost-optimized surgical device platforms.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report is one of a series of new reports from The Business Research Company that provides hepato-pancreatico-biliary (hpb) surgeries surgical devices market statistics, including hepato-pancreatico-biliary (hpb) surgeries surgical devices industry global market size, regional shares, competitors with a hepato-pancreatico-biliary (hpb) surgeries surgical devices market share, detailed hepato-pancreatico-biliary (hpb) surgeries surgical devices market segments, market trends and opportunities, and any further data you may need to thrive in the hepato-pancreatico-biliary (hpb) surgeries surgical devices industry. This hepato-pancreatico-biliary (hpb) surgeries surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market size has grown strongly in recent years. It will grow from $5.62 billion in 2025 to $5.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing incidence of liver and pancreatic diseases, expansion of specialized surgical centers, growing adoption of laparoscopic techniques, rising availability of advanced surgical instruments, improved surgeon training and expertise.
The hepato-pancreatico-biliary (hpb) surgeries surgical devices market size is expected to see strong growth in the next few years. It will grow to $7.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for robotic-assisted hpb surgeries, rising investments in high-definition visualization systems, expansion of minimally invasive oncology procedures, growing focus on precision and safety in complex surgeries, increasing adoption of integrated surgical platforms. Major trends in the forecast period include increasing adoption of advanced energy-based surgical devices, rising use of minimally invasive hpb procedures, growing integration of robotic and visualization systems, expansion of precision surgical instrumentation, enhanced focus on complex procedure safety.
The growing trend of medical tourism is expected to drive the expansion of the hepatic-pancreatic-biliary (HPB) surgical device market in the coming years. Medical tourism involves patients traveling to other countries to access specialized medical procedures that offer higher quality care, advanced technologies, and reduced waiting times. Demand for medical tourism is increasing as patients pursue affordable, high-precision surgical treatments at internationally accredited healthcare facilities. HPB surgical devices support this trend by enabling precise and minimally invasive interventions for disorders of the liver, pancreas, and bile ducts. For instance, in December 2023, according to the Centers for Medicare and Medicaid Services, a US-based federal agency, healthcare expenditure in the United States increased by 4.1% in 2023 to reach $4.5 trillion, while spending on hospital care services grew by 2.2% in the same year, totaling $1.4 trillion. Therefore, the rise in medical tourism is contributing to the growth of the hepatic-pancreatic-biliary (HPB) surgery and surgical devices market.
Major companies operating in the hepato-pancreatico-biliary (HPB) surgeries surgical devices market are emphasizing technological advancements such as integrated fluorescence-guided ICG imaging, which enables real-time evaluation of tissue perfusion, vascular networks, and biliary anatomy to improve intraoperative accuracy and surgical results. Integrated fluorescence-guided ICG imaging utilizes Indocyanine Green dye combined with near-infrared visualization to allow surgeons to view anatomical details beyond the visible spectrum, supporting clearer identification of essential HPB structures during minimally invasive procedures. For instance, in February 2024, CMR Surgical, a UK-based surgical robotics company, introduced the vLimeLite fluorescence imaging system integrated into its Versius Plus robotic platform. The system provides dual visualization modes, including full-color overlay or greyscale, along with selectable ICG color options in green or cyan, enabling surgeons to assess blood flow, vessel integrity, and biliary anatomy with greater clarity during HPB surgical procedures.
In February 2023, Olympus Corporation, a Japan-based medical technology company, agreed to acquire Taewoong Medical Co., Ltd. for approximately $370 million. Through this acquisition, Olympus seeks to reinforce its gastrointestinal EndoTherapy portfolio by incorporating advanced gastrointestinal metallic stent technologies, expanding minimally invasive treatment options, and improving patient outcomes. Taewoong Medical Co., Ltd. is a Korea-based company specializing in the manufacture of gastrointestinal metallic stents and other minimally invasive GI therapeutic devices.
Major companies operating in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market are Johnson & Johnson Services Ltd., Medtronic Plc, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, BD CooperSurgical Inc., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Smith & Nephew plc, W.L. Gore & Associates Inc., Cook Medical Inc., CONMED Corporation, Richard Wolf GmbH, CooperSurgical Inc., Medi-Globe GmbH, Thompson Surgical Instruments Inc., Lotus Surgicals Pvt. Ltd., Hobbs Medical Inc., Medorah Meditek Pvt. Ltd.
North America was the largest region in the hepatic-pancreatic-biliary (HPB) surgical device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hepato-pancreatico-biliary (HPB) surgeries surgical devices market includes revenues earned by entities by liver surgeries, ultrasonic aspirators, liver retractors, and liver transplantation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepato-pancreatico-biliary (HPB) surgeries surgical devices market also includes sales of visualization and access instruments, trocars, energy devices, and ultrasonic scalpels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hepato-pancreatico-biliary (hpb) surgeries surgical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hepato-pancreatico-biliary (hpb) surgeries surgical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hepato-pancreatico-biliary (hpb) surgeries surgical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.